Position
CONNING INC. in Biomarin Pharmaceutical Inc
Back to the book · All holders of BMRN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $14.4K$0.95 → $0.96
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.7M | $2.57M | — | — | — | 0.1% |
| Q1 2026 | 2.7M | $2.59M | $0.96 | $14.4K | −$0 | 0.1% |